Search - tctmd.com

Displaying 461 - 480 of 1118

Sort: Relevancy | Date

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

News Industry News

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

September 10, 2014

News Industry News

Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial

September 09, 2014

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

News Conference News ESC 2014

PROTECT: ZES Sustain Lead Over SES at 5 Years

Caitlin E. Cox

September 03, 2014

News Industry News

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

September 02, 2014

News Industry News

Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG

September 02, 2014

News Daily News

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

L.A. McKeown

September 02, 2014

News Daily News

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Todd Neale

September 02, 2014

News Daily News

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

September 02, 2014

News Industry News

New Clinical Trial Results Demonstrate Importance of St. Jude Medical Fractional Flow Reserve in Guiding Treatment of NSTEMI Patients

September 01, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Industry News

Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System

August 31, 2014

News Conference News ESC 2014

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Todd Neale

August 30, 2014

News Industry News

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

August 30, 2014

News Industry News

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

August 27, 2014

News Industry News

The ARROW® VPS G4™ Device, a Vascular Positioning System from Teleflex, Streamlines Placement of Central IV Catheters, Study Reports

August 25, 2014

News Industry News

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

August 25, 2014

News Daily News

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

L.A. McKeown

August 20, 2014

News Daily News

Meta-analysis: Value of PFO Closure vs Medical Therapy Varies by Device

Caitlin E. Cox

August 20, 2014

Advertisement

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

PROTECT: ZES Sustain Lead Over SES at 5 Years

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

New Clinical Trial Results Demonstrate Importance of St. Jude Medical Fractional Flow Reserve in Guiding Treatment of NSTEMI Patients

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

The ARROW® VPS G4™ Device, a Vascular Positioning System from Teleflex, Streamlines Placement of Central IV Catheters, Study Reports

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

Meta-analysis: Value of PFO Closure vs Medical Therapy Varies by Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content